Standard Chartered (LON:STAN – Free Report) had its price target upped by Citigroup from GBX 2,130 to GBX 2,230 in a research report report published on Thursday,Digital Look reports. They currently have a neutral rating on the financial services provider’s stock.
A number of other brokerages also recently issued reports on STAN. Shore Capital Group raised shares of Standard Chartered to a “sell” rating in a research report on Friday, May 1st. UBS Group restated a “buy” rating and issued a GBX 2,130 target price on shares of Standard Chartered in a research note on Monday, May 18th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,250 price target on shares of Standard Chartered in a report on Wednesday. Finally, JPMorgan Chase & Co. raised Standard Chartered to an “overweight” rating and upped their price target for the stock from GBX 2,220 to GBX 2,270 in a research report on Tuesday, July 21st. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 2,266.
View Our Latest Stock Report on Standard Chartered
Standard Chartered Stock Performance
About Standard Chartered
Standard Chartered PLC, together with its subsidiaries, provides various banking products and services in Asia, Africa, the Middle East, Europe, and the Americas. The company operates in three segments: Corporate, Commercial & Institutional Banking; Consumer, Private & Business Banking; and Ventures. It offers retail products, such as deposits, mortgages, credit cards, and personal loans; wealth management products and services that include investments, portfolio management, insurance, and wealth advice; and transaction banking services, such as cash management, working capital, and trade financing products.
Recommended Stories
- Five stocks we like better than Standard Chartered
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Standard Chartered Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Standard Chartered and related companies with MarketBeat.com's FREE daily email newsletter.
